Mettler-Toledo International (NYSE:MTD) Price Target Lowered to $1,194.00 at Robert W. Baird

Mettler-Toledo International (NYSE:MTD) had its target price dropped by stock analysts at Robert W. Baird from $1,445.00 to $1,194.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm currently has a “neutral” rating on the medical instruments supplier’s stock. Robert W. Baird’s target price would suggest a potential upside of 6.31% from the company’s previous close.

MTD has been the topic of several other research reports. Citigroup cut their price target on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a report on Friday. Morgan Stanley cut their price target on shares of Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating on the stock in a report on Tuesday, February 10th. Barclays lowered their price objective on Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. Jefferies Financial Group raised Mettler-Toledo International from a “hold” rating to a “buy” rating and raised their price objective for the company from $1,400.00 to $1,450.00 in a research report on Friday, March 20th. Finally, Wall Street Zen raised Mettler-Toledo International from a “hold” rating to a “buy” rating in a research report on Saturday, February 14th. Seven analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, Mettler-Toledo International presently has a consensus rating of “Moderate Buy” and a consensus price target of $1,444.08.

Mettler-Toledo International Stock Down 0.1%

NYSE:MTD opened at $1,123.08 on Monday. The stock has a market cap of $22.74 billion, a P/E ratio of 26.34, a price-to-earnings-growth ratio of 2.36 and a beta of 1.31. The firm’s fifty day simple moving average is $1,276.49 and its 200 day simple moving average is $1,367.66. Mettler-Toledo International has a twelve month low of $1,079.34 and a twelve month high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share for the quarter, beating the consensus estimate of $8.70 by $0.21. The business had revenue of $947.13 million for the quarter, compared to analysts’ expectations of $943.14 million. Mettler-Toledo International had a net margin of 21.40% and a negative return on equity of 622.80%. The firm’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $8.19 earnings per share. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. On average, analysts expect that Mettler-Toledo International will post 46.54 EPS for the current fiscal year.

Insider Buying and Selling

In other Mettler-Toledo International news, CFO Shawn Vadala sold 800 shares of the firm’s stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $1,410.12, for a total transaction of $1,128,096.00. Following the completion of the transaction, the chief financial officer owned 5,288 shares of the company’s stock, valued at approximately $7,456,714.56. This trade represents a 13.14% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 0.71% of the company’s stock.

Hedge Funds Weigh In On Mettler-Toledo International

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Principal Financial Group Inc. raised its position in shares of Mettler-Toledo International by 2.9% in the 3rd quarter. Principal Financial Group Inc. now owns 298,429 shares of the medical instruments supplier’s stock worth $366,354,000 after purchasing an additional 8,360 shares during the last quarter. Nordea Investment Management AB raised its position in shares of Mettler-Toledo International by 11.9% in the 4th quarter. Nordea Investment Management AB now owns 157,457 shares of the medical instruments supplier’s stock worth $220,718,000 after purchasing an additional 16,777 shares during the last quarter. Campbell & CO Investment Adviser LLC purchased a new position in shares of Mettler-Toledo International in the 3rd quarter worth about $2,210,000. Rakuten Investment Management Inc. purchased a new position in shares of Mettler-Toledo International in the 3rd quarter worth about $121,021,000. Finally, Machina Capital S.A.S. purchased a new position in shares of Mettler-Toledo International in the 3rd quarter worth about $1,186,000. Hedge funds and other institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.